Skip to main content
logo
Attovia Therapeutics, Inc. (ATTO)
NASDAQ: ATTO · Real-Time Price · USD
19.86
+0.68 (3.55%)
At close: Aug 14, 2026, 4:00 PM EDT
19.56
-0.30 (-1.51%)
After-hours: Aug 14, 2026, 7:34 PM EDT

Attovia Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Mar '26 Dec '25 Dec '24
Cash & Equivalents
43.340.1930.63
Short-Term Investments
89.33112.0838.69
Cash & Short-Term Investments
132.62152.2769.32
Cash Growth
-119.65%-
Other Receivables
0.70.90.1
Receivables
0.70.90.1
Prepaid Expenses
3.323.133.06
Total Current Assets
136.64156.372.48
Property, Plant & Equipment
7.497.873.23
Other Long-Term Assets
1.951.731
Total Assets
146.09165.8976.72

Liabilities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Mar '26 Dec '25 Dec '24
Accounts Payable
2.533.554.14
Accrued Expenses
4.845.093.58
Current Portion of Leases
1.981.92-
Current Unearned Revenue
0.450.45-
Total Current Liabilities
9.811.017.72
Long-Term Leases
2.833.34-
Other Long-Term Liabilities
0.750.766.87
Total Liabilities
13.3815.114.59

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Mar '26 Dec '25 Dec '24
Common Stock
000
Additional Paid-In Capital
4.173.473.49
Retained Earnings
-129.67-111.01-50.38
Comprehensive Income & Other
-0.030.10.07
Total Common Equity
-125.52-107.44-46.83
Shareholders' Equity
132.71150.7962.13
Total Liabilities & Equity
146.09165.8976.72

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Mar '26 Dec '25 Dec '24
Total Debt
4.85.26-
Net Cash (Debt)
127.82147.0169.32
Net Cash Growth
-112.06%-
Net Cash Per Share
31.6737.2219.63
Filing Date Shares Outstanding
4.514.434.43
Total Common Shares Outstanding
4.514.434.43
Working Capital
126.84145.2964.76
Book Value Per Share
-27.82-24.27-10.58
Tangible Book Value
-125.52-107.44-46.83
Tangible Book Value Per Share
-27.82-24.27-10.58
Machinery
4.714.431.96
Construction In Progress
-0.031.57
Leasehold Improvements
0.140.14-
SEC Filings: 10-K · 10-Q